Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
February 18, 2010
0
Date of Patent
May 22, 2012
0
Patent Application Number
12708523
0
Patent Citations Received
US Patent 11952634 Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
0
US Patent 11771687 Substituted diazaspiroalkanes as androgen receptor modulators
US Patent 11839689 Formulations of enzalutamide
0
Patent Inventor Names
Charles L. Sawyers
0
Charlie D. Chen
0
Chris Tran
0
John Wongvipat
0
Michael E. Jung
0
Samedy Ouk
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
8183274
0
Patent Primary Examiner
Yong Chu
0
Find more entities like US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE